Impact of overweight and obesity on cardiac benefit of antihypertensive treatment

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 2, 2013, Pages 122-129

  Gerdts, E ^a   de Simone, G ^b   Lund, B P ^a   Okin, P M ^c   Wachtell, K ^d   Boman, K ^e   Nieminen, M S ^f   Dahlof B ^g   Devereux, R B ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e UMEÅ UNIVERSITY   (Sweden)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass index; Left ventricular hypertrophy; Obesity

Indexed keywords

ANTIHYPERTENSIVE AGENT; LOSARTAN;

AGED; ARTICLE; BIOASSAY; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; OVERWEIGHT; STROKE; TREATMENT OUTCOME;

EID: 84873458932     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.03.008     Document Type: Article

References (38)

1. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
2. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999, 341:1097-1105.
3. de Simone G., Devereux R.B., Mureddu G.F., Roman M.J., Ganau A., Alderman M.H., et al. Influence of obesity on left ventricular midwall mechanics in arterial hypertension. Hypertension 1996, 28:276-283.
4. Mureddu G.F., de Simone G., Greco R., Rosato G.F., Contaldo F. Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders. Hypertension 1997, 29:544-550.
5. Gottdiener J.S., Reda D.J., Materson B.J., Massie B.M., Notargiacomo A., Hamburger R.J., et al. Importance of obesity, race and age to the cardiac structural abd functional effects of hypertension: the department of veterans affairs cooperative study group on antihypertensive agents. J Am Coll Cardiol 1994, 24:1492-1498.
6. Devereux R.B., Dahlöf B., Gerdts E., Boman K., Nieminen M.S., Papademetriou V., et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004, 110:1456-1462.
7. de Simone G., Wachtell K., Palmieri V., Hille D.C., Beevers G., Dahlöf B., et al. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study. Circulation 2005, 111:1924-1931.
8. de Simone G., Okin P.M., Gerdts E., Olsen M.H., Wachtell K., Hille D.C., et al. Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. Nutr Metab Cardiovasc Dis 2009, 19:634-640.
9. Devereux R.B., Bella J., Boman K., Gerdts E., Nieminen M.S., Rokkedal J., et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Blood Press 2001, 10:74-82.
10. Dahlöf B., Devereux R.B., Julius S., Kjeldsen S.E., Beevers G., de Faire U., et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension 1998, 32:989-997.
11. Dahlöf B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., de Faire U., et al. LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995-1003.
12. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998, 6(Suppl. 2):51S-209S. National Institutes of Health.
13. Diabetes mellitus (technical report series 727) 1985, WHO Study Group, WHO, Geneva.
14. Jensen J.S., Clausen P., Borch-Johnsen K., Jensen G., Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant 1997, 12(Suppl. 2):6-9.
15. Wachtell K., Smith G., Gerdts E., Dahlof B., Nieminen M.S., Papademetriou V., et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol 2000, 85:466-472.
16. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Chamber quantification writing group; American society of echocardiography's guidelines and standards committee; European association of echocardiography. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
17. Palmieri V., Dahlöf B., DeQuattro V., Roman M.J., RT Hahn, Sharpe N., et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. J Am Coll Cardiol 1999, 34:1625-1632.
18. Wachtell K., Bella J.N., Liebson P.R., Gerdts E., Dahlof B., Roman M.J., et al. Impact of different partition values on the prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000, 35:6-12.
19. Palmieri V., de Simone G., Arnett D.K., Bella J.N., Kitzman D.W., Oberman A., et al. Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The hypertension genetic epidemiology network study). Am J Cardiol 2001, 88:1163-1168.
20. Roman M.J., Pickering T.G., Schwartz J.E., Pini R., Devereux R.B. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996, 28:751-756.
21. Gaasch W.H., Zile M.R., Hoshino P.K., Apstein C.S., Blaustein A.S. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989, 79:872-883.
22. de Simone G., Devereux R.B., Roman M.J., Ganau A., Saba P.S., Alderman M.H., et al. Assessment of left ventricular function by midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994, 23:1444-1451.
23. Jones E.C., Devereux R.B., Roman M.J., Liu J.E., Fishman D., Lee E.T., et al. Prevalence and correlates of mitral regurgitation in a population-based sample (the strong heart study). Am J Cardiol 2001, 87:298-304.
24. Lebowitz N.E., Bella J.N., Roman M.J., Liu J.E., Fishman D.P., Paranicas M., et al. Prevalence and correlates of aortic regurgitation in American Indians: the strong heart study. J Am Coll Cardiol 2000, 36:461-467.
25. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 1991, 83:356-362.
26. Snapinn S.M., Jiang Q., Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 2005, 59:301-307.
27. Burke G.L., Bertoni A.G., Shea S., Watson K.E., Blumenthal R.S., Chung H., et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease. Arch Intern Med 2008, 168:928-935.
28. Gerdts E., Cramariuc D., de Simone G., Wachtell K., Dahlöf B., Devereux R.B. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008, 9:809-815.
29. Gerdts E., Okin P.M., Omvik P., Wachtell K., Dahlöf B., Hildebrandt P., et al. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. Nutr Metab Cardiovasc Dis 2009, 19:306-312.
30. Ammar K.A., Redfield M.M., Mahoney D.W., Johnson M., Jacobsen S.J., Rodeheffer R.J. Central obesity: association with left ventricular dysfunction and mortality in the community. Am Heart J 2008, 156:975-981.
31. Kuznetsova T., Herbots L., Richart T., D'hooge J., Thijs L., Fagard R.H., et al. Left ventricular strain and strain rate in a general population. Eur Heart J 2008, 29:2014-2023.
32. Ferreira I., Twisk J.W.R., van Mechelen W., Kemper H.C.G., Seidell J.C.S., Stehouwer C.D.A. Current and adolescent body fatness and fat distribution: relationship with carotid intima-media thickness and large artery stiffness at age 36. J Hypertens 2004, 22:145-155.
33. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes and obesity-related health risk factors. JAMA 2001, 2003(289):76-79.
34. Sjöström L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Swedish obese subjects study. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
35. Sjöström L., Narbro K., Sjöström C.D., Karason K., Larsson B., Wedel H., et al. Swedish obese subjects study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752.
36. Hubert H.B., Feinleib M., McNamara P.M., Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983, 67:968-977.
37. Klenk J., Nagel G., Ulmer H., Strasak A., Concin H., Diem G., et al. VHM&PP study group. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol 2009, 24:83-91.
38. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037.